ArticleJournal of medical virology2025
Co-Infection Patterns of Beta, Gamma, and Alpha HPV Types in Cervical and Anal Sites in HIV-Positive Women.
Article in Journal of medical virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study investigates the prevalence of beta (β) and gamma (γ) human papillomavirus (HPV) types in cervical and anal samples from women living with HIV and examines their association with alpha (α) HPV and cytological lesions. Cervical and anal swabs were collected from 138 women. Detection of β- and γ-HPV types were performed using bead-based assays, and data analysis included only samples with adequate DNA quality, as confirmed by β-globin amplification. The analysis revealed higher rates of β-HPV in anal samples (51.7%) compared to cervical samples (30.3%), with β-1 species being predominant in both sites. Furthermore, γ-HPV types were more prevalent in anal samples (36.5%) than in cervical site (16.9%), with γ-10 being the most frequently detected species. Concordance between cervical and anal samples for specific β-HPV types (κ = 0.20, 95% CI: 0.03-0.36) and γ-HPV types (κ = 0.17, 95% CI: 0.003-0.36) was poor. Co-infections with both β- and γ-HPV types in cervical samples was significantly associated with co-infection at the anal site (OR 7.7; 95% CI: 1.44-38.25; p = 0.01). There was no statistically significant association (p > 0.05) between β-HPV positivity and neoplastic precancerous lesions (LSIL or HSIL) at either the cervical or anal site. Similarly, γ-HPV positivity showed no significant association (p > 0.05) with cytological abnormalities in cervical or anal samples. In conclusion, while the prevalence of β- and γ-HPV types is higher in the anal region among HIV-positive women, the absence of a strong association with neoplastic lesions underscores their limited oncogenic potential compared to high-risk α-HPV types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.